Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-012370
Filing Date
2021-06-17
Accepted
2021-06-17 18:46:59
Documents
1
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4148
  Complete submission text file 0001567619-21-012370.txt   5551
Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Nielsen Jack (Reporting) CIK: 0001602402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39617 | Film No.: 211026384

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Issuer) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)